[Hemolytic-uremic syndrome after myomectomy].
Bravo
J J
JJ
Novoa
D
D
Romero
R
R
Sánchez-Guisande
D
D
D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology* / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D007889:Leiomyoma / Q000601:surgery*; D008775:Methylprednisolone / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D010949:Plasma; D010956:Plasmapheresis; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis; D011183:Postoperative Complications / Q000209:etiology*; D006435:Renal Dialysis; D014594:Uterine Neoplasms / Q000601:surgery*
D002121:Calcium Channel Blockers; D017395:Plasminogen Activator Inhibitor 1; D009543:Nifedipine; D008775:Methylprednisolone